Oncora Funding: How Much Did They Raise & Key Investors

How Much Did Oncora Raise?
Funding & Key Investors

Oncora has successfully secured a total capital infusion of $2.5M, marking a significant milestone in its trajectory within the health-tech sector. This latest major strategic investment of $1.3M underscores the market confidence in the company's specialized approach to oncology data management. By consolidating its financial position, Oncora is well-positioned to accelerate its mission of transforming how healthcare facilities handle complex cancer registry workflows.

The company's growth trajectory, evidenced by its progression from early-stage backing to more substantial financing rounds, reflects a maturing business model. This capital injection serves as a critical catalyst for scaling operations and refining the technological infrastructure that supports its core product offerings.

What is Oncora?

Oncora

Software

Healthcare Software

Oncora provides a sophisticated Cancer Registry Assistant, a platform engineered to optimize quality control and data integrity within oncology departments. By automating and streamlining the management of cancer registries, the firm addresses a critical pain point for healthcare providers: the administrative burden of maintaining accurate, high-quality clinical data. In an era where precision medicine relies heavily on structured data, Oncora's intelligent assistant serves as a vital bridge between raw clinical information and actionable insights. The company targets a diverse client base, including large-scale healthcare facilities and specialized cancer registries, aiming to enhance operational efficiency and ensure compliance with rigorous data standards.

How much funding has Oncora raised?

Oncora has raised a total of $2.5M across 2 funding rounds:

2016

Angel/Seed

$1.2M

2017

Unspecified

$1.3M

Angel/Seed (2016): $1.2M with participation from BioAdvance and iSeed Ventures

Unspecified (2017): $1.3M, investors not publicly disclosed

Key Investors in Oncora

BioAdvance

BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life.

iSeed Ventures

iSeed Ventures is a San Francisco-based venture capital firm that invests in innovative companies across various sectors, particularly those leveraging AI technology.

Undisclosed Investors

What's next for Oncora?

With the recent influx of capital, Oncora is poised to transition into a phase of aggressive market expansion and product enhancement. The strategic focus will likely shift toward deepening the integration of its Cancer Registry Assistant within existing electronic health record systems, thereby increasing its utility for clinical teams. Furthermore, the company is expected to leverage this financing to bolster its research and development efforts, potentially incorporating advanced machine learning capabilities to further automate data validation processes. As the demand for high-fidelity oncology data continues to rise, Oncora's ability to scale its enterprise-level solutions will be a key determinant of its long-term success in the competitive digital health landscape.

See full Oncora company page

See More Financial Insights